Immediate Impact

7 standout
Sub-graph 1 of 3

Citing Papers

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD
2024 Standout
2 intermediate papers

Works of Felipe Rey being referenced

Regional subgroup analysis of the phase 3 TOPAZ-1 study of durvalumab (D) plus gemcitabine and cisplatin (GC) in advanced biliary tract cancer (BTC).
2022

Author Peers

Author Last Decade Papers Cites
Felipe Rey 10 14 21 16 4 38
James Pinilla 8 8 7 7 5 55
Eden Stotsky‐Himelfarb 13 14 14 4 5 42
Ilka Kolodziej 7 6 20 39 5 48
John G. Archie 25 7 36 22 6 175
Alejandro Molina Alavez 16 27 18 13 2 43
Terence Roberts 13 27 16 4 46
Richard Lo 13 7 18 5 42
Roel Schlijper 29 20 21 5 54
Nawaz Walji 14 15 13 15 6 48
Brian Kim-Poh Goh 15 20 32 3 57

All Works

Loading papers...

Rankless by CCL
2026